obesity drugs

obesity overweight weight loss weigh
Biotech

Response’s ex-Sanofi asset hits goal in post-GLP-1 patients

Response shared phase 2 data, linking its asset to reductions in blood-fat levels and weight gain in post-GLP-1 patients.
Nick Paul Taylor Aug 13, 2025 9:14am
Yellow tape measure with a variety of weight loss medication on blue background

Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial

Aug 7, 2025 6:30am
dominoes stop stall halt end red

Terns vows to stop funding metabolic disease trials beyond 2025

Aug 6, 2025 6:20am
Image of brain with hindbrain highlighted

Mice given a brain protein lost weight without getting nauseous

Jul 24, 2025 7:00am
pivot change turnaround direction walk away

Roche axes Carmot obesity asset, 3 cancer drugs in R&D clear-out

Jul 24, 2025 5:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Rhythm’s obesity pill trial hits primary goal, sending stock up

Jul 9, 2025 10:21am